青光眼：概述
Glaucoma: an overview.
作者信息
Johnson D H, Brubaker R F
出版信息
Mayo Clin Proc. 1986 Jan;61(1):59-67. doi: 10.1016/s0025-6196(12)61399-8.
PMID:3510342
Abstract
Glaucoma is a potentially blinding ocular disease that commonly affects elderly persons. In this review, we discuss the range of clinical findings, appropriate diagnostic tests, and available medical, laser, and surgical treatment options. New developments in the evaluation of the optic nerve and in visual field testing may facilitate the early detection of glaucoma, and new therapeutic agents hold promise for the future.
摘要
青光眼是一种可能导致失明的眼部疾病，常见于老年人。在本综述中，我们讨论了一系列临床发现、合适的诊断测试以及现有的药物、激光和手术治疗选择。视神经评估和视野测试方面的新进展可能有助于青光眼的早期检测，新的治疗药物也为未来带来了希望。
相似文献
1
Glaucoma: an overview.青光眼：概述
Mayo Clin Proc. 1986 Jan;61(1):59-67. doi: 10.1016/s0025-6196(12)61399-8.
2
Management of glaucoma in the aphakic eye.
Int Ophthalmol Clin. 1984 Fall;24(3):43-8.
3
Glaucoma detection: a three-step technique.青光眼检测：一种三步技术。
Am Fam Physician. 1973 Sep;8(3):136-41.
4
Review: the medical management of open angle glaucoma.
Can J Ophthalmol. 1978 Apr;13(2):123-7.
5
Open-angle glaucoma: diagnosis and management.开角型青光眼：诊断与管理
Hosp Pract (Off Ed). 1983 Oct;18(10):114C, 114F, 114J passim. doi: 10.1080/21548331.1983.11702662.
6
Principles of medical management in chronic open angle glaucoma.慢性开角型青光眼的医学管理原则
Ann Ophthalmol. 1971 Jun;3(6):579-86.
7
Open angle glaucoma in melanosis oculi: response to laser trabeculoplasty.
Ann Ophthalmol. 1985 Jan;17(1):33-6.
8
Primary therapy for chronic simple glaucoma the role of argon laser trabeculoplasty.
Trans Ophthalmol Soc U K (1962). 1985;104 ( Pt 1):62-6.
9
Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma.与激光和药物治疗相比，早期手术治疗开角型青光眼后的长期功能预后。
Ophthalmology. 1994 Oct;101(10):1651-6; discussion 1657. doi: 10.1016/s0161-6420(94)31120-1.
10
The treatment of open- and narrow-angle glaucoma.
S Afr Med J. 1971 Apr 10;45(15):391-4.
引用本文的文献
1
Repurposing Alzheimer's disease medications-systemic cholinesterase inhibitors-for the treatment of dry eye syndrome, glaucoma, and age-related macular degeneration.将用于治疗阿尔茨海默病的药物——全身性胆碱酯酶抑制剂——重新用于治疗干眼症、青光眼和年龄相关性黄斑变性。
Ther Adv Ophthalmol. 2025 May 16;17:25158414251341022. doi: 10.1177/25158414251341022. eCollection 2025 Jan-Dec.
Zotero 插件